Philadelphia chromosome positive childhood acute lymphoblastic leukemia. 1980

J R Priest, and L L Robison, and R W McKenna, and L L Lindquist, and P I Warkentin, and T W LeBien, and W G Woods, and J H Kersey, and P F Coccia, and M E Nesbit

In a 3-yr period, the Philadelphia chromosome (Ph1) was found in 4 of 43 children with acute lymphoblastic leukemia (ALL) in whom chromosomes were studied at diagnosis. The clinical, morphological, cytochemical, and immunologic findings in the Ph1-positive (PH1+) CASES WERE CONsistent with typical childhood ALL, indicating that identification of cases requires chromosome studies. A review of all reported cases of Ph1 + childhood ALL shows that Ph1 + patients are older and have higher initial platelet and white blood cell counts (WBC) than most children with ALL. However, a life table comparison between the reported cases of Ph1 + ALL in children and randomly selected age-, sex-, and WBC-matched controls with ALL shows the duration of first marrow remission to be significantly shorter (p less than 0.02) for the Ph1 + cases Ph1 + ALL is a distinct subtype of childhood ALL that is not rare and can be identified only by cytogenetic studies. The prognosis is poor. Cytogenetic studies should be done prospectively in a large group of children with ALL to define further the subgroup of patients and to confirm the findings of this retrospective analysis.

UI MeSH Term Description Entries
D007621 Karyotyping Mapping of the KARYOTYPE of a cell. Karyotype Analysis Methods,Analysis Method, Karyotype,Analysis Methods, Karyotype,Karyotype Analysis Method,Karyotypings,Method, Karyotype Analysis,Methods, Karyotype Analysis
D007945 Leukemia, Lymphoid Leukemia associated with HYPERPLASIA of the lymphoid tissues and increased numbers of circulating malignant LYMPHOCYTES and lymphoblasts. Leukemia, Lymphocytic,Lymphocytic Leukemia,Lymphoid Leukemia,Leukemias, Lymphocytic,Leukemias, Lymphoid,Lymphocytic Leukemias,Lymphoid Leukemias
D008297 Male Males
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D002904 Chromosomes, Human, 21-22 and Y The short, acrocentric human chromosomes, called group G in the human chromosome classification. This group consists of chromosome pairs 21 and 22 and the Y chromosome. Chromosomes G,Group G Chromosomes,Chromosomes, Human, 21 22,Chromosomes, Human, 21-22,Chromosome, Group G,Chromosomes, Group G,Group G Chromosome
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

J R Priest, and L L Robison, and R W McKenna, and L L Lindquist, and P I Warkentin, and T W LeBien, and W G Woods, and J H Kersey, and P F Coccia, and M E Nesbit
March 2011, Korean journal of pediatrics,
J R Priest, and L L Robison, and R W McKenna, and L L Lindquist, and P I Warkentin, and T W LeBien, and W G Woods, and J H Kersey, and P F Coccia, and M E Nesbit
December 2015, Hematology (Amsterdam, Netherlands),
J R Priest, and L L Robison, and R W McKenna, and L L Lindquist, and P I Warkentin, and T W LeBien, and W G Woods, and J H Kersey, and P F Coccia, and M E Nesbit
February 1993, Hematology/oncology clinics of North America,
J R Priest, and L L Robison, and R W McKenna, and L L Lindquist, and P I Warkentin, and T W LeBien, and W G Woods, and J H Kersey, and P F Coccia, and M E Nesbit
October 2009, Hematology/oncology clinics of North America,
J R Priest, and L L Robison, and R W McKenna, and L L Lindquist, and P I Warkentin, and T W LeBien, and W G Woods, and J H Kersey, and P F Coccia, and M E Nesbit
June 2022, The New England journal of medicine,
J R Priest, and L L Robison, and R W McKenna, and L L Lindquist, and P I Warkentin, and T W LeBien, and W G Woods, and J H Kersey, and P F Coccia, and M E Nesbit
January 1983, Klinische Padiatrie,
J R Priest, and L L Robison, and R W McKenna, and L L Lindquist, and P I Warkentin, and T W LeBien, and W G Woods, and J H Kersey, and P F Coccia, and M E Nesbit
June 1980, Hiroshima journal of medical sciences,
J R Priest, and L L Robison, and R W McKenna, and L L Lindquist, and P I Warkentin, and T W LeBien, and W G Woods, and J H Kersey, and P F Coccia, and M E Nesbit
June 2013, Current hematologic malignancy reports,
J R Priest, and L L Robison, and R W McKenna, and L L Lindquist, and P I Warkentin, and T W LeBien, and W G Woods, and J H Kersey, and P F Coccia, and M E Nesbit
January 2007, Nihon rinsho. Japanese journal of clinical medicine,
J R Priest, and L L Robison, and R W McKenna, and L L Lindquist, and P I Warkentin, and T W LeBien, and W G Woods, and J H Kersey, and P F Coccia, and M E Nesbit
December 2009, Leukemia & lymphoma,
Copied contents to your clipboard!